DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma

clinical trial

MedicalStudy clinical_trial Q61939256

Press Enter · cited answer in seconds

Summary

DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma is a clinical trial^[1].

Key Facts

DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma is in the country of Spain^[2].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's instance of is recorded as clinical trial^[3].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's start time is recorded as +2009-12-31T00:00:00Z^[4].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's end time is recorded as +2010-12-31T00:00:00Z^[5].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's sponsor is recorded as Hospital Universitario Príncipe de Asturias^[6].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's main subject is recorded as lymphoma^[7].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's number of participants is recorded as {'unit': '1', 'amount': '+30'}^[8].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's title is recorded as Treatment With Infusional Dose-adjusted Etoposide/Vincristine/Doxorubicin/Bolus Cyclophosphamide/Dexamethasone and Rituximab (DA-EDOCH14-R) in Patients With Poor-prognosis Diffuse Large B-cell Lymphoma^[9].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's ClinicalTrials.gov ID is recorded as NCT01066429^[11].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[12].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's research intervention is recorded as dexamethasone acetate^[13].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's research intervention is recorded as (RS)-cyclophosphamide^[14].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's research intervention is recorded as rituximab^[15].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's clinical trial phase is recorded as phase II clinical trial^[16].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's research subject recruitment status is recorded as Coronavirus^[17].
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma's study type is recorded as interventional study^[18].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

End timeP582

2012-12 2026-09-26 Wikidata lists 2010-12-31 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country Spain

Properties

Clinical trial phase phase II clinical trial

End time December 31, 2010

Imported from wholeness_audit_2026-05-02

Main subject lymphoma

Maximum age 70 year

Minimum age 18 year

Number of participants 30

Research intervention dexamethasone acetate, (RS)-cyclophosphamide, rituximab

Research subject recruitment status Coronavirus

Sponsor Hospital Universitario Príncipe de Asturias

Start time December 31, 2009

Study type interventional study

Title Treatment With Infusional Dose-adjusted Etoposide/Vincristine/Doxorubicin/Bolus Cyclophosphamide/Dexamethasone and Rituximab (DA-EDOCH14-R) in Patients With Poor-prognosis Diffuse Large B-cell Lymphoma

External References (1)

Clinicaltrials.gov id NCT01066429

🏷️ Also known as

en DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma. Retrieved May 3, 2026, from https://4ort.xyz/entity/da-edoch14-r-in-poor-prognosis-diffuse-large-b-cell-lymphoma

MLA

“DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/da-edoch14-r-in-poor-prognosis-diffuse-large-b-cell-lymphoma.

BibTeX

@misc{4ortxyz_da-edoch14-r-in-poor-prognosis-diffuse-large-b-cell-lymphoma_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma}}, year = {2026}, url = {https://4ort.xyz/entity/da-edoch14-r-in-poor-prognosis-diffuse-large-b-cell-lymphoma}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma — https://4ort.xyz/entity/da-edoch14-r-in-poor-prognosis-diffuse-large-b-cell-lymphoma (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/da-edoch14-r-in-poor-prognosis-diffuse-large-b-cell-lymphoma · Last refreshed: May 3, 2026